Balance Sheet Siemens Healthineers AG

Equities

SHL

DE000SHL1006

Advanced Medical Equipment & Technology

Market Closed - Xetra Other stock markets 16:35:01 09/02/2026 GMT			After hours 17:11:10
40.80 ^EUR	-1.45%		40.90	+0.25%

04:56pm	German Shares Extend Winning Streak; Commerzbank Gains	MT
11:46am	SIEMENS HEALTHINEERS : Buy rating from Bernstein	ZD

2c8d.42jtMJLSGYzYMVYvxATJIGOEUKAN-AOgElSS9OWM_jM.1A6vAP6AXr2sYgVVjTH5VzHVFc93oDaZJgDRs9HFh2GKDZhpoZNj9LRSGw

Published financial data: SIEMENS HEALTHINEERS AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	18B	21.71B	21.68B	22.36B	23.38B
Total Revenues	18B	21.71B	21.68B	22.36B	23.38B
Cost of Goods Sold, Total	11.04B	13.58B	13.97B	13.9B	14.34B
Gross Profit	6.95B	8.14B	7.71B	8.47B	9.03B
Selling General & Admin Expenses, Total	2.82B	3.41B	3.61B	3.68B	3.89B
R&D Expenses	1.55B	1.78B	1.87B	1.92B	1.96B
Other Operating Expenses	32M	20M	103M	60M	21M
Other Operating Expenses, Total	4.4B	5.21B	5.58B	5.66B	5.87B
Operating Income	2.56B	2.92B	2.13B	2.81B	3.16B
Interest Expense, Total	-83M	-118M	-296M	-476M	-425M
Interest And Investment Income	33M	48M	85M	119M	99M
Net Interest Expenses	-50M	-70M	-211M	-357M	-326M
Income (Loss) On Equity Invest.	5M	2M	3M	-2M	-10M
Currency Exchange Gains (Loss)	-273M	-2.02B	1.2B	564M	328M
Other Non Operating Income (Expenses)	242M	1.97B	-1.2B	-491M	-303M
EBT, Excl. Unusual Items	2.48B	2.8B	1.93B	2.52B	2.85B
Merger & Related Restructuring Charges	-89M	-	-	-	-
Other Unusual Items	11M	-	-	-	-
EBT, Incl. Unusual Items	2.4B	2.8B	1.93B	2.52B	2.85B
Income Tax Expense	658M	746M	403M	564M	686M
Earnings From Continuing Operations	1.74B	2.06B	1.52B	1.96B	2.17B
Net Income to Company	1.74B	2.06B	1.52B	1.96B	2.17B
Minority Interest	-18M	-17M	-16M	-17M	-23M
Net Income - (IS)	1.73B	2.04B	1.51B	1.94B	2.14B
Net Income to Common Incl Extra Items	1.73B	2.04B	1.51B	1.94B	2.14B
Net Income to Common Excl. Extra Items	1.73B	2.04B	1.51B	1.94B	2.14B
Per Share Items
Net EPS - Basic	1.57	1.82	1.35	1.74	1.91
Basic EPS - Continuing Operations	1.57	1.82	1.35	1.74	1.91
Basic Weighted Average Shares Outstanding	1.1B	1.12B	1.12B	1.12B	1.12B
Net EPS - Diluted	1.57	1.81	1.34	1.73	1.91
Diluted EPS - Continuing Operations	1.57	1.81	1.34	1.73	1.91
Diluted Weighted Average Shares Outstanding	1.1B	1.13B	1.12B	1.12B	1.12B
Normalized Basic EPS	1.39	1.54	1.06	1.4	1.57
Normalized Diluted EPS	1.39	1.54	1.06	1.39	1.56
Dividend Per Share	0.85	0.95	0.95	0.95	1
Payout Ratio	49.57	46.86	70.64	54.74	49.72
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	3.3B	3.94B	3.21B	3.74B	4.07B
EBITA	2.84B	3.39B	2.64B	3.21B	3.56B
EBIT	2.56B	2.92B	2.13B	2.81B	3.16B
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	27.38	26.63	20.9	22.35	24.04
Total Current Taxes	745M	1.01B	668M	768M	987M
Total Deferred Taxes	-87M	-266M	-265M	-204M	-301M
Normalized Net Income	1.53B	1.73B	1.19B	1.56B	1.76B
Non-Cash Pension Expense	12M	8M	22M	18M	22M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.67B	1.91B	1.96B	2.01B	2.07B
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	92M	106M	124M	143M	152M
Total Stock-Based Compensation	92M	106M	124M	143M	152M

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.32B	1.44B	1.64B	2.68B	2.18B
Total Cash And Short Term Investments	1.32B	1.44B	1.64B	2.68B	2.18B
Accounts Receivable, Total	5.61B	6.52B	6.76B	6.41B	6.56B
Other Receivables	445M	546M	723M	798M	706M
Total Receivables	6.06B	7.06B	7.48B	7.2B	7.26B
Inventory	3.18B	4.01B	4.29B	4.18B	4.14B
Prepaid Expenses	-	-	206M	180M	185M
Other Current Assets, Total	268M	870M	510M	196M	338M
Total Current Assets	10.82B	13.38B	14.14B	14.44B	14.1B
Gross Property Plant And Equipment	6.95B	7.75B	8B	8.47B	8.63B
Accumulated Depreciation	-3.65B	-4.12B	-4.29B	-4.6B	-4.72B
Net Property Plant And Equipment	3.3B	3.63B	3.7B	3.87B	3.92B
Long-term Investments	179M	202M	210M	194M	112M
Goodwill	17.51B	19.06B	18.12B	17.66B	17.12B
Other Intangibles, Total	8.21B	8.71B	7.73B	7.06B	6.5B
Accounts Receivable Long-Term	212M	255M	287M	306M	303M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	481M	575M	416M	476M	410M
Other Long-Term Assets, Total	1.45B	3.24B	2.09B	2.04B	1.9B
Total Assets	42.16B	49.06B	46.68B	46.06B	44.37B
Liabilities
Accounts Payable, Total	1.93B	2.32B	2.21B	2.15B	2.3B
Accrued Expenses, Total	1.81B	1.63B	1.82B	1.84B	1.77B
Short-term Borrowings	-	-	-	96M	92M
Current Portion of Long-Term Debt	1.98B	2.66B	4.22B	2.47B	3.17B
Current Portion of Leases	176M	183M	180M	184M	187M
Current Income Taxes Payable	468M	609M	462M	391M	675M
Unearned Revenue Current, Total	2.88B	3.75B	3.63B	3.63B	3.64B
Other Current Liabilities	826M	869M	924M	814M	806M
Total Current Liabilities	10.06B	12.02B	13.44B	11.57B	12.64B
Long-Term Debt	11.68B	13.34B	11.81B	12.92B	10.84B
Long-Term Leases	485M	471M	450M	534M	505M
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	908M	668M	539M	592M	488M
Deferred Tax Liability Non Current	2.08B	2.11B	1.66B	1.51B	1.15B
Other Non Current Liabilities	603M	591M	651M	677M	655M
Total Liabilities	25.82B	29.2B	28.55B	27.81B	26.28B
Common Stock, Total	1.13B	1.13B	1.13B	1.13B	1.13B
Retained Earnings	-300M	894M	1.38B	2.15B	3.24B
Treasury Stock	-240M	-405M	-607M	-433M	-539M
Comprehensive Income and Other	15.73B	18.22B	16.18B	15.35B	14.21B
Total Common Equity	16.32B	19.84B	18.08B	18.2B	18.04B
Minority Interest	18M	16M	52M	49M	51M
Total Equity	16.34B	19.85B	18.13B	18.25B	18.09B
Total Liabilities And Equity	42.16B	49.06B	46.68B	46.06B	44.37B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.12B	1.12B	1.12B	1.12B	1.12B
ECS Total Common Shares Outstanding	1.12B	1.12B	1.12B	1.12B	1.12B
Book Value / Share	14.54	17.72	16.2	16.26	16.15
Tangible Book Value	-9.4B	-7.94B	-7.76B	-6.52B	-5.59B
Tangible Book Value Per Share	-8.37	-7.09	-6.96	-5.83	-5
Total Debt	14.32B	16.65B	16.65B	16.21B	14.79B
Net Debt	12.99B	15.22B	15.01B	13.53B	12.62B
Debt Equivalent of Unfunded Proj. Benefit Obligation	821M	521M	372M	450M	340M
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	18M	16M	52M	49M	51M
Equity Method Investments, Total	33M	32M	35M	30M	19M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	644M	1.22B	1.29B	1.31B	1.34B
Inventories - Work In Process, Total	1.08B	1.04B	1.16B	1.15B	1.1B
Inventories - Finished Goods, Total	1.43B	1.72B	1.81B	1.69B	1.64B
Inventories - Others	25M	36M	32M	36M	49M
Land - (BS)	1.66B	1.95B	2.18B	2.21B	2.24B
Machinery, Total	2.31B	2.47B	2.56B	2.74B	2.81B
Full Time Employees	66K	69.5K	71K	72K	70.9K
Part Time Employees	-	-	-	-	2.94K
Assets on Operating Lease - Gross	2.01B	2.21B	2.06B	2.11B	2.13B
Assets on Operating Lease - Accumulated Depreciation	-1.09B	-1.21B	-1.15B	-1.16B	-1.14B
Order Backlog	27B	34B	34B	35B	36B

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	1.73B	2.04B	1.51B	1.94B	2.14B
Depreciation & Amortization - CF	628M	751M	792M	731M	728M
Amortization of Goodwill and Intangible Assets - (CF)	285M	469M	503M	404M	394M
Depreciation & Amortization, Total	913M	1.22B	1.3B	1.14B	1.12B
Amortization of Deferred Charges, Total - (CF)	126M	123M	-	88M	110M
(Gain) Loss From Sale Of Asset	-2M	21M	81M	-34M	-30M
Asset Writedown & Restructuring Costs	-	-	262M	-	64M
Other Operating Activities, Total	-185M	-67M	-426M	36M	390M
Change In Accounts Receivable	-720M	-478M	-769M	-443M	-417M
Change In Inventories	-22M	-481M	-453M	39M	-76M
Change In Accounts Payable	318M	247M	-20M	-62M	229M
Change in Unearned Revenues	325M	544M	141M	88M	164M
Change in Other Net Operating Assets	453M	-663M	499M	37M	-168M
Cash from Operations	2.93B	2.5B	2.12B	2.83B	3.53B
Capital Expenditure	-674M	-852M	-838M	-696M	-818M
Cash Acquisitions	-13.47B	-29M	-235M	-46M	-216M
Divestitures	-	-2M	-	-	3M
Investment in Marketable and Equity Securities, Total	0	15M	5M	76M	126M
Other Investing Activities, Total	1M	-	-1M	-	-1M
Cash from Investing	-14.14B	-868M	-1.07B	-666M	-906M
Short Term Debt Issued, Total	-	-	-	52M	3M
Long-Term Debt Issued, Total	-	-	-	-	61M
Total Debt Issued	-	-	-	52M	64M
Short Term Debt Repaid, Total	-17M	-20M	-42M	-47M	-1.07B
Long-Term Debt Repaid, Total	-138M	-149M	-190M	-216M	-193M
Total Debt Repaid	-155M	-169M	-232M	-263M	-1.26B
Issuance of Common Stock	2.31B	-	-	-	-
Repurchase of Common Stock	-255M	-309M	-421M	-	-301M
Common Dividends Paid	-856M	-955M	-1.07B	-1.06B	-1.07B
Common & Preferred Stock Dividends Paid	-856M	-955M	-1.07B	-1.06B	-1.07B
Other Financing Activities, Total	10.79B	-211M	1.03B	-383M	-474M
Cash from Financing	11.84B	-1.64B	-690M	-1.66B	-3.04B
Foreign Exchange Rate Adjustments	34M	122M	-155M	-66M	-97M
Miscellaneous Cash Flow Adjustments	-	-	1M	-	1M
Net Change in Cash	666M	114M	206M	437M	-508M
Supplemental Items
Cash Interest Paid	150M	248M	310M	357M	449M
Cash Income Tax Paid (Refund)	808M	877M	899M	845M	577M
Levered Free Cash Flow	4.95B	1.09B	1.04B	2.03B	2.49B
Unlevered Free Cash Flow	5B	1.16B	1.23B	2.33B	2.75B
Change In Net Working Capital	-2.94B	1.26B	688M	97M	-210M
Net Debt Issued / Repaid	-155M	-169M	-232M	-211M	-1.2B

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.75	4.02	2.78	3.79	4.37
Return on Total Capital	6.57	5.47	3.74	5.07	5.87
Return On Equity %	12.1	11.45	8.03	10.77	11.93
Return on Common Equity	11.99	11.36	7.96	10.71	11.83
Margin Analysis
Gross Profit Margin %	38.63	37.47	35.56	37.87	38.63
SG&A Margin	15.65	15.69	16.64	16.46	16.63
EBITDA Margin %	18.31	18.15	14.81	16.71	17.43
EBITA Margin %	15.79	15.63	12.16	14.37	15.22
EBIT Margin %	14.21	13.47	9.84	12.56	13.54
Income From Continuing Operations Margin %	9.7	9.46	7.03	8.76	9.27
Net Income Margin %	9.6	9.39	6.96	8.68	9.17
Net Avail. For Common Margin %	9.6	9.39	6.96	8.68	9.17
Normalized Net Income Margin	8.52	7.98	5.48	6.98	7.53
Levered Free Cash Flow Margin	27.48	5.01	4.8	9.08	10.64
Unlevered Free Cash Flow Margin	27.77	5.35	5.66	10.41	11.78
Asset Turnover
Asset Turnover	0.54	0.48	0.45	0.48	0.52
Fixed Assets Turnover	6.2	6.27	5.91	5.91	6.01
Receivables Turnover (Average Receivables)	2.91	3.59	3.27	3.56	3.61
Inventory Turnover (Average Inventory)	4.03	3.78	3.37	3.28	3.45
Short Term Liquidity
Current Ratio	1.08	1.11	1.05	1.25	1.11
Quick Ratio	0.73	0.71	0.68	0.85	0.75
Operating Cash Flow to Current Liabilities	0.29	0.21	0.16	0.24	0.28
Days Sales Outstanding (Average Receivables)	125.62	101.57	111.78	102.81	101.23
Days Outstanding Inventory (Average Inventory)	90.6	96.62	108.46	111.59	105.77
Average Days Payable Outstanding	50.36	53.85	58.04	57.9	56.84
Cash Conversion Cycle (Average Days)	165.86	144.34	162.2	156.49	150.17
Long Term Solvency
Total Debt/Equity	87.62	83.89	91.84	88.83	81.78
Total Debt / Total Capital	46.7	45.62	47.87	47.04	44.99
LT Debt/Equity	74.45	69.57	67.6	73.73	62.69
Long-Term Debt / Total Capital	39.68	37.83	35.24	39.05	34.49
Total Liabilities / Total Assets	61.25	59.53	61.16	60.38	59.23
EBIT / Interest Expense	30.81	24.78	7.21	5.9	7.44
EBITDA / Interest Expense	41.81	35.12	11.58	8.29	10.08
(EBITDA - Capex) / Interest Expense	33.69	27.9	8.75	6.82	8.16
Total Debt / EBITDA	4.13	4.02	4.86	4.11	3.45
Net Debt / EBITDA	3.74	3.67	4.38	3.43	2.94
Total Debt / (EBITDA - Capex)	5.12	5.06	6.43	4.99	4.27
Net Debt / (EBITDA - Capex)	4.65	4.62	5.8	4.16	3.64
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	24.46	20.65	-0.16	3.15	4.53
Gross Profit, 1 Yr. Growth %	24.59	17.05	-5.26	9.85	6.64
EBITDA, 1 Yr. Growth %	31.73	19.17	-18.52	15.7	9.05
EBITA, 1 Yr. Growth %	33.11	18.93	-22.31	21.89	10.74
EBIT, 1 Yr. Growth %	31.53	13.86	-27.05	31.69	12.64
Earnings From Cont. Operations, 1 Yr. Growth %	22.63	17.76	-25.79	28.46	10.62
Net Income, 1 Yr. Growth %	22.4	18.01	-25.96	28.69	10.4
Normalized Net Income, 1 Yr. Growth %	28.94	16.83	-31.42	31.19	12.84
Diluted EPS Before Extra, 1 Yr. Growth %	12.14	15.29	-25.97	29.1	10.4
Accounts Receivable, 1 Yr. Growth %	-17.23	17.08	3.73	4.08	2.37
Inventory, 1 Yr. Growth %	37.98	26.11	7.11	-2.68	-1.05
Net Property, Plant and Equip., 1 Yr. Growth %	31.27	10.23	2.01	4.4	1.22
Total Assets, 1 Yr. Growth %	68.02	17	-4.84	-1.35	-3.66
Tangible Book Value, 1 Yr. Growth %	-707.36	-16.39	-2.19	-15.95	-14.34
Common Equity, 1 Yr. Growth %	30.59	23.69	-8.85	0.65	-0.87
Cash From Operations, 1 Yr. Growth %	52.13	-14.63	-15.38	33.36	24.98
Capital Expenditures, 1 Yr. Growth %	21.01	26.41	-1.64	-16.95	17.53
Levered Free Cash Flow, 1 Yr. Growth %	-473.93	-78.43	-4.29	22.05	22.49
Unlevered Free Cash Flow, 1 Yr. Growth %	-491.93	-77.2	5.56	25.93	18.25
Dividend Per Share, 1 Yr. Growth %	6.25	11.76	0	0	5.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.34	22.54	9.76	1.48	3.84
Gross Profit, 2 Yr. CAGR %	9.52	20.76	5.3	2.01	8.23
EBITDA, 2 Yr. CAGR %	8.4	25.5	-1.46	-2.64	12.32
EBITA, 2 Yr. CAGR %	7.75	26.06	-3.88	-2.69	16.18
EBIT, 2 Yr. CAGR %	5.53	22.64	-8.86	-1.99	21.79
Earnings From Cont. Operations, 2 Yr. CAGR %	4.93	20.17	-6.52	-2.36	19.2
Net Income, 2 Yr. CAGR %	4.98	20.18	-6.52	-2.38	19.2
Normalized Net Income, 2 Yr. CAGR %	6.47	20.77	-10.49	-5.14	21.67
Diluted EPS Before Extra, 2 Yr. CAGR %	0.06	13.7	-7.61	-2.23	19.39
Accounts Receivable, 2 Yr. CAGR %	14.17	-1.94	10.2	-0.86	3.22
Inventory, 2 Yr. CAGR %	24.11	31.91	16.22	2.1	-1.87
Net Property, Plant and Equip., 2 Yr. CAGR %	30.19	20.29	6.04	3.2	2.79
Total Assets, 2 Yr. CAGR %	40.27	39.82	5.52	-3.11	-2.51
Tangible Book Value, 2 Yr. CAGR %	386.65	126.43	-9.57	-9.33	-15.15
Common Equity, 2 Yr. CAGR %	29.26	25.98	6.18	-4.22	-0.11
Cash From Operations, 2 Yr. CAGR %	34.68	13.96	-15	6.24	29.11
Capital Expenditures, 2 Yr. CAGR %	7.89	23.68	11.5	-9.62	-1.2
Levered Free Cash Flow, 2 Yr. CAGR %	65.42	-9.31	-54.56	36.65	22.27
Unlevered Free Cash Flow, 2 Yr. CAGR %	62.86	-4.55	-50.94	41.59	22.03
Dividend Per Share, 2 Yr. CAGR %	3.08	8.97	5.72	0	2.6
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.25	14.36	14.45	7.51	2.49
Gross Profit, 3 Yr. CAGR %	8.33	11.97	11.38	6.8	3.53
EBITDA, 3 Yr. CAGR %	11.03	12	8.67	4.15	1.11
EBITA, 3 Yr. CAGR %	10.42	11.5	7.28	4.04	1.6
EBIT, 3 Yr. CAGR %	9.25	8.39	3.14	3.04	2.66
Earnings From Cont. Operations, 3 Yr. CAGR %	10.77	9.04	2.33	3.93	1.78
Net Income, 3 Yr. CAGR %	10.93	9.16	2.26	3.99	1.7
Normalized Net Income, 3 Yr. CAGR %	11.51	8.64	0.01	1.68	0.51
Diluted EPS Before Extra, 3 Yr. CAGR %	7.61	4.9	-1.45	3.29	1.81
Accounts Receivable, 3 Yr. CAGR %	8.31	14.84	-0.08	4.8	0.21
Inventory, 3 Yr. CAGR %	20.23	24.77	23.06	9.55	1.04
Net Property, Plant and Equip., 3 Yr. CAGR %	26.39	23.16	13.86	5.49	2.53
Total Assets, 3 Yr. CAGR %	28.74	31.79	22.99	3.18	-3.29
Tangible Book Value, 3 Yr. CAGR %	105.02	171.41	71.17	-11.75	-11.03
Common Equity, 3 Yr. CAGR %	23.54	26.63	13.1	4.31	-3.11
Cash From Operations, 3 Yr. CAGR %	22.51	15.69	3.2	-1.23	12.15
Capital Expenditures, 3 Yr. CAGR %	8.34	13.74	14.59	1.08	-1.35
Levered Free Cash Flow, 3 Yr. CAGR %	26.46	-15.57	-7.66	-26.15	31.75
Unlevered Free Cash Flow, 3 Yr. CAGR %	24.76	-14.89	-1.29	-22.97	33.34
Dividend Per Share, 3 Yr. CAGR %	6.69	5.9	5.9	3.78	1.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.85	9.69	10.05	9.02	10.08
Gross Profit, 5 Yr. CAGR %	4.92	7.4	7.11	7.88	10.11
EBITDA, 5 Yr. CAGR %	4.44	7.59	5.92	5.9	10.24
EBITA, 5 Yr. CAGR %	4.14	7.24	4.54	5.59	10.75
EBIT, 5 Yr. CAGR %	3.85	5.63	1.7	4.12	10.23
Earnings From Cont. Operations, 5 Yr. CAGR %	5.61	8.04	3.5	4.33	8.78
Net Income, 5 Yr. CAGR %	5.67	8.13	3.59	4.38	8.73
Normalized Net Income, 5 Yr. CAGR %	5.34	7.3	1.47	2.9	8.17
Diluted EPS Before Extra, 5 Yr. CAGR %	3.67	5.59	1.24	1.98	6.41
Accounts Receivable, 5 Yr. CAGR %	-1.44	3.11	8.9	8.28	-0.65
Inventory, 5 Yr. CAGR %	19.44	20.09	18.61	15.15	12.41
Net Property, Plant and Equip., 5 Yr. CAGR %	18.19	20.61	17.82	14.75	9.3
Total Assets, 5 Yr. CAGR %	15.75	18.37	18.76	16.53	12.07
Tangible Book Value, 5 Yr. CAGR %	4.59	4.94	48.06	75.05	29.27
Common Equity, 5 Yr. CAGR %	47.05	43.31	15.87	13.25	7.62
Cash From Operations, 5 Yr. CAGR %	9.67	4.86	5.85	11.81	12.87
Capital Expenditures, 5 Yr. CAGR %	9.71	12.83	9.6	3.75	7.99
Levered Free Cash Flow, 5 Yr. CAGR %	32.26	12.54	-15.7	2.36	13.47
Unlevered Free Cash Flow, 5 Yr. CAGR %	29.78	8.59	-13.78	4.33	16.65
Dividend Per Share, 5 Yr. CAGR %	-	-	6.3	3.5	4.56